Results 141 to 150 of about 169,723 (293)

Maximizing Efficacy of Cancer Nanovaccines and Immune Cells Landscape in Responders and Non‐Responders to Immunotherapy

open access: yesAdvanced Science, EarlyView.
To maximize the efficacy of cancer vaccines, adjuvants, collection, lysis, purification, oxidation, loading sites, and sizes, etc., are investigated. The optimized cancer nanovaccines loading whole tumor antigens can cure all or most tumor‐bearing mice in multiple mouse cancer models.
Xiangxiang Xu   +13 more
wiley   +1 more source

Intralesional interferon-alpha therapy in advanced malignant melanoma

open access: bronze, 1988
Peter von Wussow   +3 more
openalex   +1 more source

Demonstration of two subtypes of human leukocyte interferon (IFN-alpha) by monoclonal antibodies. [PDF]

open access: bronze, 1982
Makoto Imai   +10 more
openalex   +1 more source

Pyruvate Carboxylase in Macrophages Aggravates Atherosclerosis by Regulating Metabolism Reprogramming to Promote Inflammatory Responses Through the Hypoxia‐Inducible Factor‐1 Signaling Pathway

open access: yesAdvanced Science, EarlyView.
This study investigates the role of macrophage pyruvate carboxylase (PC) in atherosclerosis (AS) demonstrating that PC upregulation in macrophages promotes metabolism reprogramming to enhance inflammatory responses via the HIF‐1 signaling pathway.
Ling‐Na Zhao   +17 more
wiley   +1 more source

Family of human alpha-interferon-like sequences.

open access: green, 1985
Sheldon I. Feinstein   +6 more
openalex   +1 more source

Efficacy of gamma and alpha interferon (IFN) in the treatment of hairy cell leukemia (HCL) [PDF]

open access: bronze, 1986
N. Niederle   +4 more
openalex   +1 more source

Localized Delivery of the mRNAs Encoding CD47 Inhibitor and Interleukins 12, 15, and 21 Elicits Robust Antitumor Immunity

open access: yesAdvanced Science, EarlyView.
The co‐delivery of mRNAs encoding a CD47 inhibitor and a cytokine cocktail (interleukins 12, 15, and 21) via lipid nanoparticles enables effective localized immunotherapy. This strategy not only suppresses tumor progression but also enhances type 1 conventional dendritic cell (cDC1) differentiation and activates CD8+ T cells, thereby inducing robust ...
Tao Jiang   +14 more
wiley   +1 more source

IFNA2: The prototypic human alpha interferon. [PDF]

open access: yesGene, 2015
Paul F, Pellegrini S, Uzé G.
europepmc   +1 more source

Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells [PDF]

open access: bronze, 1986
C Billard   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy